Press releaseGlobe Newswire
BIOAGE Labs
BIOA · NASDAQ
$5.56+$0.57 (+11.42%)TodayMarket closed ·
Prev close $4.99
Latest news
- News
10 Health Care Stocks With Whale Alerts In Today’s Session
- Press releaseGlobe Newswire
BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema
- Press releasePRNewswire
Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
- Press releaseGlobe Newswire
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
- NewsVandana Singh
Why Is BioAge Labs Stock Sinking Friday?
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- NewsAvi Kapoor
Nasdaq Surges 300 Points; Amazon Shares Jump Following Upbeat Earnings
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releasePRNewswire
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
- Press releaseGlobe Newswire
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
- Press releasePRNewswire
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
- Press releasePRNewswire
A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Avaí Bio's Cell-Based Platform Approach
- Press releaseGlobe Newswire
BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
- NewsAvi Kapoor
Fastenal, Replimune Group, Children's Place And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- Press releaseGlobe Newswire
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025
- Press releasePRNewswire
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
- NewsAvi Kapoor
Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why Penguin Solutions Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday
- NewsAvi Kapoor
Donaldson Posts Upbeat Results, Joins Science Applications International, Descartes Systems, Dollar General And Other Big Stocks Moving Higher On Thursday
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- Press releasePRNewswire
HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor
- Press releaseGlobe Newswire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- Press releaseGlobe Newswire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- Press releaseGlobe Newswire
Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates Claims on Your Behalf
- Press releaseGlobe Newswire
Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates Claims on Your Behalf
- Press releaseGlobe Newswire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)
- Press releaseGlobe Newswire
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
- Press releasePRNewswire
BioArctic receives Orphan Drug Designation for exidavnemab the US
- Press releasePRNewswire
Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA
- Press releasePRNewswire
BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
- Press releaseBusiness Wire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- Press releaseGlobe Newswire
Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
- Press releaseGlobe Newswire
BIOA FINAL DEADLINE: BioAge Labs Investors are Encouraged to Contact BFA Law before the Expiration of Today's Class Action Deadline
- Press releasePRNewswire
BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
- Press releasePRNewswire
BIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- Press releaseGlobe Newswire
BIOA LEGAL NEWS: A Class Action was filed on behalf of BioAge Labs Investors - Contact BFA Law if You Suffered Losses
- Press releaseGlobe Newswire
BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman
- Press releaseGlobe Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.